BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24560897)

  • 1. Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels.
    Zapponi KC; Mazetto BM; Bittar LF; Barnabé A; Santiago-Bassora FD; De Paula EV; Orsi FA; Franco-Penteado CF; Conran N; Annichino-Bizzacchi JM
    Thromb Res; 2014 May; 133(5):736-42. PubMed ID: 24560897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ADAMTS13 activity in patients with venous thromboembolism.
    Mazetto BM; Orsi FL; Barnabé A; De Paula EV; Flores-Nascimento MC; Annichino-Bizzacchi JM
    Thromb Res; 2012 Dec; 130(6):889-93. PubMed ID: 23031329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism].
    Liu FF; Zhai ZG; Yang YH; Wang J; Wang C
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1860-3. PubMed ID: 24124734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis.
    Xu PC; Lin S; Yang XW; Gu DM; Yan TK; Wei L; Wang BL
    BMC Immunol; 2015 Mar; 16():10. PubMed ID: 25879749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
    Zhang PP; Sun JW; Wang XY; Liu XM; Li K
    Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of elevated D-dimer in patients admitted to a large urban emergency department.
    Lippi G; Bonfanti L; Saccenti C; Cervellin G
    Eur J Intern Med; 2014 Jan; 25(1):45-8. PubMed ID: 23948628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event.
    Zapponi KCS; Orsi FA; Cunha JLR; de Brito IR; Romano AVC; Bittar LF; De Paula EV; Penteado CF; Montalvão S; Annichino-Bizzacchi JM
    J Thromb Thrombolysis; 2022 Jan; 53(1):30-42. PubMed ID: 34449018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
    Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
    Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-dimer before chemotherapy might predict venous thromboembolism.
    Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophils of rheumatoid arthritis patients on anti-TNF-α therapy and in disease remission present reduced adhesive functions in association with decreased circulating neutrophil-attractant chemokine levels.
    Dominical VM; Bértolo MB; Almeida CB; Garrido VT; Miguel LI; Costa FF; Conran N
    Scand J Immunol; 2011 Apr; 73(4):309-18. PubMed ID: 21208248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low CD34(+) cells, high neutrophils and the metabolic syndrome are associated with an increased risk of venous thromboembolism.
    Rattazzi M; Villalta S; Galliazzo S; Del Pup L; Sponchiado A; Faggin E; Bertacco E; Buso R; Seganfreddo E; Pagliara V; Callegari E; Puato M; Caberlotto L; Scannapieco G; Fadini GP; Pauletto P
    Clin Sci (Lond); 2013 Aug; 125(4):211-8. PubMed ID: 23506051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease.
    Sakamoto TM; Canalli AA; Traina F; Franco-Penteado CF; Gambero S; Saad ST; Conran N; Costa FF
    Clin Biochem; 2013 Dec; 46(18):1798-803. PubMed ID: 24060729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
    Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED).
    Sen B; Kesteven P; Avery P
    J Clin Pathol; 2014 May; 67(5):437-40. PubMed ID: 24307452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.